is the most clinically consequential of the childhood disruptive behavior disorders, defined by a persistent pattern of behavior that violates the rights of others or major age-appropriate norms. It sits within the chapter on Disruptive, Impulse-Control, and Conduct Disorders and is the developmental antecedent of in a substantial minority of cases. Two features anchor the modern conceptualization: the childhood-onset versus adolescent-onset distinction, which predicts very different trajectories, and the specifier, which identifies a callous-unemotional subgroup with worse prognosis and reduced responsiveness to standard behavioral treatment. First-line treatment is psychosocial — , , and functional family therapy carry the strongest evidence — while pharmacotherapy is reserved for severe aggression or specific comorbidities. The bottom line: identify the subtype, treat the family system, screen aggressively for comorbid and substance use, and resist the pull to medicate first.
Conduct disorder is common but uneven in its distribution by age, sex, and social context. Prevalence estimates depend heavily on informant, instrument, and the diagnostic threshold applied.
Prevalence and demographics
- Lifetime prevalence in community samples is approximately 9-12% in males and 3-7% in females, with a pooled global past-year prevalence of roughly 3% in children and adolescents. 1
- The male-to-female ratio is approximately 2.5-4:1 in childhood-onset cases and narrows in adolescence. 1
- Onset before age 10 (childhood-onset type) is less common than adolescent-onset but carries substantially worse prognosis. 1
- Prevalence is elevated in urban, low-income, and child-welfare-involved populations, and among youth in juvenile justice settings where rates exceed 50%. 1,6
Comorbidity
- ADHD co-occurs in roughly 30-50% of children with conduct disorder and predicts earlier onset and more aggressive presentations. 1,7
- frequently precedes conduct disorder, though most children with ODD do not progress. 1
- , , and substance use disorders co-occur at rates two to four times the general adolescent population. 1
- Learning disorders and language impairment are common and frequently under-recognized. 1
- Completed suicide and suicide attempts are elevated, particularly in females and in those with comorbid depression or substance use. 1
Risk factors
- Individual: difficult temperament, low resting heart rate, lower verbal IQ, executive dysfunction, and . 1
- Family: harsh or inconsistent parenting, parental antisocial behavior, parental substance use, maternal smoking during pregnancy, and maltreatment. 1
- Peer and community: deviant peer affiliation, neighborhood disadvantage, and exposure to community violence. 1
Conduct disorder is best understood as a heterogeneous, multifactorial with substantial gene-environment interplay rather than a single neurobiological lesion. The childhood-onset and callous-unemotional subgroups appear to have partially distinct neurobiological substrates from adolescent-onset cases.
Genetics
- Twin studies estimate heritability of antisocial behavior at approximately 40-60%, with higher heritability for early-onset, persistent, and callous-unemotional presentations. 1
- No single gene of large effect has been identified; candidate gene work has implicated MAOA, particularly its interaction with childhood maltreatment, though replication has been mixed. 1
Neurobiology
- Structural and functional imaging in youth with conduct disorder show reduced gray matter volume and reduced reactivity to fearful faces, especially in those with high callous-unemotional traits. 1
- The and circuits linking the amygdala, , and anterior insula are implicated in impaired empathy and reinforcement learning. 1
- Autonomic underarousal — low resting heart rate and reduced skin conductance — is one of the most replicated biological correlates of antisocial behavior. 1
- findings are mixed, with some studies reporting blunted cortisol reactivity in callous-unemotional subgroups. 1
Environmental contributors
- Prenatal exposures (maternal smoking, alcohol, malnutrition) modestly elevate risk. 1
- Childhood maltreatment, particularly physical abuse and neglect, is among the strongest environmental predictors. 1
- Coercive family processes — escalating cycles of parent-child negative reinforcement first characterized by Patterson — are central to current behavioral models. 2
Integrative model
- Childhood-onset cases typically combine neurodevelopmental vulnerability (executive dysfunction, language deficits, callous-unemotional traits) with adverse family environments. 1
- Adolescent-onset cases are more often explained by peer-driven social mimicry of antisocial behavior in the absence of major neurodevelopmental loading. 1
Conduct disorder is defined in DSM-5-TR by a repetitive and persistent pattern of behavior that violates the basic rights of others or major age-appropriate societal norms or rules. The clinician must count specific behaviors, set a duration threshold, and assign subtype, severity, and specifier.
DSM-5-TR core criteria
- Criterion A: at least 3 of 15 listed behaviors in the past 12 months, with at least 1 in the past 6 months, drawn from four behavioral categories. 3
- Aggression to people and animals: bullying, fighting, use of a weapon, physical cruelty to people, physical cruelty to animals, robbery, forced sexual activity. 3
- Destruction of property: deliberate fire-setting, other deliberate destruction. 3
- Deceitfulness or theft: breaking into a building or vehicle, conning others, stealing without confrontation. 3
- Serious violations of rules: staying out at night before age 13 against parental rules, running away overnight at least twice, frequent truancy beginning before age 13. 3
- Criterion B: clinically significant impairment in social, academic, or occupational functioning. 3
- Criterion C: if the individual is 18 or older, criteria for antisocial personality disorder are not met. 3
Subtypes by age of onset
- Childhood-onset: at least one criterion characteristic of conduct disorder before age 10. 3
- Adolescent-onset: no criteria characteristic before age 10. 3
- Unspecified onset: criteria met but age of onset cannot be established. 3
Severity
- Mild: few conduct problems beyond those required, and conduct problems cause relatively minor harm. 3
- Moderate: number and effects of conduct problems intermediate between mild and severe. 3
- Severe: many conduct problems beyond those required, or conduct problems cause considerable harm to others. 3
Limited prosocial emotions specifier
- Applied when the youth has displayed at least two of the following persistently over at least 12 months, in multiple relationships and settings, reflecting the typical pattern of functioning rather than occasional occurrence. 3
- Multiple informants are required because youth may underreport these traits. 3
ICD-11 differences
- uses the term and groups it with oppositional defiant disorder under disruptive behaviour or dissocial disorders. 4
- ICD-11 includes a similar limited prosocial emotions qualifier and an age-of-onset distinction, but does not require a fixed three-symptom count. 4
- ICD-11 explicitly recognizes that symptoms must exceed normative levels of misbehavior for the individual's developmental stage and cultural context. 4
Conduct disorder presents along a continuum from rule-breaking and truancy to severe aggression, theft, and predatory behavior. Trajectory and treatment response depend heavily on age of onset, sex, and the presence of callous-unemotional traits.
Prototypical presentations
- Childhood-onset, male, with comorbid ADHD: oppositional behavior in preschool progressing to fighting, cruelty to animals, theft, and school refusal, often with executive dysfunction and learning problems. 1
- Adolescent-onset, mixed sex: emergence of truancy, substance use, shoplifting, and property destruction in the context of deviant peer affiliation, often resolving by early adulthood. 1
- Callous-unemotional subgroup: planned, instrumental aggression; reduced fear and guilt; manipulative interpersonal style; poor response to standard contingency-based interventions. 1
Sex-specific patterns
- Males more often display overt physical aggression, vandalism, and fighting. 1
- Females more often display relational aggression, running away, truancy, lying, and early sexual risk behavior. 1,13
- Females with conduct disorder have higher rates of comorbid depression and suicide attempts than males. 1,13
Course features
- Many youth with oppositional defiant disorder do not progress to conduct disorder; the minority who do tend to have early-onset ODD, callous-unemotional features, and adverse family environments. 1
- Roughly 40% of children with conduct disorder go on to meet criteria for antisocial personality disorder in adulthood; the remainder follow heterogeneous trajectories including remission, persistent non-criminal antisocial traits, or other psychiatric disorders. 1,13
Red flags
- Cruelty to animals, fire-setting, and use of a weapon predict severe and persistent aggression. 1
- Onset before age 8, callous-unemotional traits, low verbal IQ, and parental antisocial personality disorder identify a high-risk trajectory. 1
- Acute escalation in a previously stable adolescent should prompt evaluation for substance use, depression, traumatic brain injury, or victimization. 1
The differential is broad because rule-breaking and aggression are common, nonspecific behaviors in adolescence. Distinguishing conduct disorder from its mimics determines whether treatment targets behavior, mood, attention, substance use, or a medical condition.
Psychiatric differential
- Oppositional defiant disorder: defiant, angry, vindictive behavior without violation of others' basic rights; can coexist or precede conduct disorder. 3
- : discrete episodes of impulsive aggression without the broader rule-violating pattern. 3
- ADHD: impulsivity and rule-breaking driven by inattention and disinhibition rather than premeditated violation of others' rights; commonly comorbid. 3
- : persistent irritability with severe temper outbursts beginning before age 10; the prevailing affective state is angry, not antisocial. 3
- Bipolar disorder: episodic mood elevation with grandiosity, decreased need for sleep, and pressured speech; conduct symptoms may emerge during manic episodes. 3
- Major depressive disorder: irritable mood in adolescence may drive aggression; vegetative and anhedonic features point to depression. 3
- : reactive aggression in the context of intrusive symptoms, hyperarousal, and trauma history. 3
- : aggression driven by sensory overload, communication failure, or rigidity rather than instrumental rule-breaking. 3
- Adjustment disorder with disturbance of conduct: time-limited conduct symptoms in response to an identifiable stressor, falling short of full criteria. 3
- Substance use disorders: conduct problems may be substance-induced or substance-driven; both diagnoses are given when criteria are met. 3
Medical and neurological mimics
- Traumatic brain injury, particularly frontal lobe injury, can produce disinhibition and aggression. 1
- Temporal lobe epilepsy may present with episodic aggression and post-ictal confusion. 1
- Thyroid disease, hypoglycemia, and Wilson disease can produce behavioral disturbance in youth. 1
- Intoxication or withdrawal from alcohol, cannabis, stimulants, or anabolic steroids can mimic or worsen conduct symptoms. 1
- Fetal alcohol spectrum disorders produce executive dysfunction and behavioral disinhibition that overlap with conduct disorder. 1
Assessment of conduct disorder is multi-informant by design — the youth, at least one caregiver, and, when possible, the school must contribute. Functional impairment and antecedent-behavior-consequence patterns matter more than any single rating-scale score.
Interview approach
- Build rapport before probing antisocial behavior; adolescents often deny acts a caregiver will report. 5
- Interview youth and caregivers separately and together to capture discrepancies and family dynamics. 5
- Use a developmental timeline from preschool forward, noting the age at which each problem behavior first appeared. 5
- Screen for trauma history, including witnessed violence, in every case. 5
Mandatory history elements
- Prenatal and perinatal history, including maternal substance use. 5
- Developmental milestones, language acquisition, and academic trajectory. 5
- Family psychiatric history with attention to antisocial personality disorder, substance use, and incarceration. 5
- Maltreatment, child protective services involvement, and out-of-home placements. 5
- Substance use, weapon access, and prior involvement with the juvenile justice system. 5
- Suicide risk and history of self-harm. 5
Physical exam
- Document injuries that may indicate fighting, abuse, or self-harm. 5
- Look for stigmata of substance use, anabolic steroid use, and neurological soft signs. 5
- Note dysmorphology suggestive of fetal alcohol spectrum disorders or other genetic syndromes. 5
Validated rating scales
- (CBCL) and Teacher Report Form: broad-band parent and teacher ratings with externalizing scales. 1,6
- (SDQ): brief screening across multiple informants. 6
- (ICU): assesses the limited prosocial emotions specifier. 1
- (APSD): callous-unemotional and antisocial features. 1
- (MOAS): tracks aggression severity for treatment monitoring. 5
Laboratories and imaging
- Order labs by clinical question rather than reflexively; conduct disorder has no diagnostic test. 5
- Toxicology screen when substance use is suspected or in acute behavioral change. 5
- TSH, CBC, basic metabolic panel, and lead level when indicated by exposure history. 5
- Neuroimaging only with focal neurological signs, post-traumatic onset, or suspected seizure. 5
- EEG for suspected seizure activity, not for aggression in isolation. 5
Treatment of conduct disorder is led by psychosocial interventions delivered to the family and the youth's broader social system, not by medication. Pharmacotherapy is adjunctive, targeting aggression or comorbid disorders rather than conduct disorder itself.
General principles
- Match intensity to severity: brief parent training for mild presentations; multi-modal, ecologically based interventions for severe presentations. 6
- Treat comorbid ADHD, depression, anxiety, PTSD, and substance use directly; untreated comorbidity blocks behavioral progress. 6
- Engage the family system; isolated individual therapy with the youth has limited evidence. 6
- Avoid aggregating high-risk adolescents in group-based programs, which can produce iatrogenic peer-contagion effects. 1,6
Psychotherapy
- Parent management training (Incredible Years, , Triple P) is first-line for children under approximately age 12, with strong evidence for reduction in conduct problems. 6,12
- Multisystemic therapy (MST) is recommended for adolescents with serious antisocial behavior, delivered in home and community with a low therapist caseload. 6
- Functional family therapy (FFT) targets family communication and contingencies in adolescents with conduct problems, with moderate evidence in juvenile justice populations. 6
- Multidimensional treatment foster care (Treatment Foster Care Oregon) is an evidence-based alternative to group placement for severe cases. 6
- Cognitive-behavioral skills training (Problem-Solving Skills Training, Anger Coping, Coping Power) shows moderate effects for school-age children, particularly when combined with parent training. 6
Pharmacotherapy
- No medication is FDA-approved for conduct disorder itself; pharmacotherapy is symptom-targeted. 6,8
- Stimulants reduce aggression and conduct symptoms in youth with comorbid ADHD; evidence supports methylphenidate and amphetamine formulations. 5,7
- Second-generation antipsychotics — risperidone has the strongest evidence — reduce severe aggression in youth, with effect sizes most robust in disruptive behavior disorders accompanied by subaverage IQ. 8
- Mood stabilizers (, valproate) have limited evidence for impulsive aggression in conduct disorder and are typically reserved for cases unresponsive to psychosocial treatment and antipsychotic trials. 5-6
- Alpha-2 agonists (clonidine, guanfacine) may reduce reactive aggression, particularly in younger children with ADHD comorbidity. 5
- Antidepressants are not first-line for aggression but treat comorbid depression and anxiety. 5
Neuromodulation
- No neuromodulation therapy is indicated for conduct disorder in current guidelines. 6
Adjunctive
- School-based interventions, individualized education plans, and tutoring address co-occurring learning problems. 6
- Substance use treatment is essential when comorbid; conduct disorder predicts poorer substance treatment response. 6
- Mentoring programs and prosocial peer engagement show modest benefits for adolescent-onset cases. 6
- Juvenile justice diversion programs that incorporate family-based evidence-based treatments outperform incarceration on recidivism. 6,10
| Intervention | Evidence base/Comparator | Benefits | Harms | Certainty | Notes |
|---|---|---|---|---|---|
| Parent management training | Cochrane review of 13 RCTs (n≈1,078) vs waitlist/usual care [12] | SMD −0.53 child conduct (parent-reported), −0.44 (independent observation); parental mental health SMD −0.36 | Low; time and engagement burden | moderate | First-line for childhood-onset cases |
| Multisystemic therapy | RCTs in juvenile justice samples vs usual care/incarceration | Reduces rearrest and out-of-home placement | Resource-intensive; mixed effects across replications | moderate | Best evidence for serious adolescent antisocial behavior |
| Functional family therapy | RCTs vs usual probation services | Reduces recidivism and family conflict | Requires trained therapists; variable fidelity | moderate | Used widely in juvenile justice diversion |
| Cognitive-behavioral skills training | RCTs vs no treatment | Small-to-moderate effects on aggression and problem-solving | Limited generalization without parent component | low | Best combined with parent training |
| Risperidone | RCTs in disruptive behavior with subaverage IQ | Reduces severe aggression | Weight gain, sedation, metabolic effects, prolactin elevation | moderate | Symptom-targeted; not for conduct disorder itself |
| Stimulants (when ADHD comorbid) | RCTs and meta-analyses in comorbid ADHD plus conduct disorder | Reduces aggression and conduct symptoms | Appetite suppression, sleep disturbance, cardiovascular monitoring | moderate | Treats the comorbidity that drives many conduct problems |
| Lithium / valproate | Small RCTs in aggressive youth | Possible reduction in impulsive aggression | Narrow therapeutic window (lithium), hepatic and hematologic monitoring (valproate) | low | Reserved for refractory aggression |
| Group-based delinquency programs | RCTs and follow-up studies | Mixed; some iatrogenic peer-contagion effects | Potential worsening of antisocial behavior | low | Avoid aggregating high-risk adolescents |
Harms in conduct disorder care arise less from the disorder's psychosocial treatments and more from the medications used for aggression and from systemic mishandling. The evidence base is robust in some areas and surprisingly thin in others.
Harms of pharmacotherapy
- Second-generation antipsychotics in youth produce dose-dependent weight gain, dyslipidemia, insulin resistance, hyperprolactinemia, sedation, and extrapyramidal symptoms. 8
- Stimulants commonly cause appetite suppression, sleep disturbance, and modest blood pressure and heart rate elevation; cardiovascular screening before initiation is standard. 7
- Lithium requires narrow-window monitoring and is rarely a comfortable choice in adolescents with chaotic adherence. 5
- Valproate is teratogenic and contraindicated in adolescents capable of pregnancy without robust contraception counseling. 5
Harms of system-level interventions
- Group-based interventions that aggregate antisocial adolescents can worsen behavior through peer reinforcement. 1,6
- Incarceration and juvenile detention without evidence-based family treatment are associated with higher recidivism than community-based alternatives. 6,10
- Out-of-home placement disrupts schooling and family contingencies and is justified only when safety cannot otherwise be assured. 6
Limitations of the evidence base
- Most trials enroll predominantly male, school-age samples; the evidence for adolescent females and for callous-unemotional subgroups is thinner. 1
- Long-term follow-up beyond 2-3 years is uncommon, and effects on adult criminal outcomes are inconsistently measured. 1
- Implementation fidelity drives much of the variance in real-world outcomes for parent management training, MST, and FFT. 6
- Publication bias favors positive trials of brand-name programs, complicating direct comparisons. 1,8
Treatment must be tailored across developmental stage, sex, comorbidity, and cultural context. A one-size protocol applied across these groups will fail.
Pediatric considerations
- Preschool-onset disruptive behavior is best treated with parent-child interaction therapy and family-focused approaches. 6
- School-age children respond best to combined parent training plus child skills training. 6
- Avoid antipsychotics in young children unless aggression is severe and refractory; cardiometabolic risk accumulates over years of exposure. 8
Adolescent considerations
- Engagement is the central challenge; ecological and family-based models (MST, FFT) outperform office-based individual therapy. 6
- Screen aggressively for substance use, traumatic exposure, and sexual risk behavior at every visit. 5
- Address school engagement, vocational skills, and prosocial activities as treatment targets. 6
Females
- Conduct disorder in girls more often co-occurs with depression, PTSD, and early pregnancy; trauma-informed approaches are essential. 1
- Relational aggression and early sexual risk behavior may be missed by male-normed measures. 1
Callous-unemotional subgroup
- Standard contingency-based parent training has reduced effect sizes; warmth-based parent training and reward-focused approaches show preliminary promise. 1,11
- Punitive responses tend to be ineffective and may worsen the trajectory. 1
Comorbid intellectual disability
- Functional behavioral analysis and applied behavior analysis are central; the evidence for risperidone in aggression is strongest in this group. 8
Cultural considerations
- Threshold for some criterion behaviors (e.g., curfew violations, fighting) varies by cultural context, and clinicians must distinguish normative responses to adverse environments from disorder. 3
- Engagement and retention in evidence-based treatments improve with culturally adapted delivery and bilingual providers. 6
Conduct disorder is not a uniformly poor-prognosis condition; outcome depends on subtype, comorbidity, and access to evidence-based treatment. Roughly half the variance in adult outcome is captured by childhood predictors that can be measured at first presentation.
Natural history
- Childhood-onset cases follow a more persistent course with higher rates of adult antisocial personality disorder, incarceration, and substance use disorders. 1
- Adolescent-onset cases more often desist by early adulthood, though substance use and educational disruption can persist. 1
- Approximately 40% of children with conduct disorder meet criteria for antisocial personality disorder by adulthood; many of the rest meet criteria for other psychiatric disorders. 1,13
Mortality and suicide
- Conduct disorder is associated with elevated all-cause mortality in early adulthood, driven by violence, accidents, and suicide. 1
- Suicide risk is elevated, particularly with comorbid depression, substance use, and female sex. 1,13
Functional outcomes
Conduct disorder generates emergency presentations through aggression, weapon use, suicidality, substance use, and victimization. The acute task is risk stratification and disposition, not diagnostic refinement.
Hospitalization criteria
- Imminent danger to self or others, including credible threats with means and intent. 5
- Acute psychiatric comorbidity (severe depression, psychosis, acute substance withdrawal) that cannot be managed outpatient. 5
- Caregiver capacity to maintain safety has acutely collapsed. 5
Acute aggression management
- De-escalation, environmental modification, and verbal limit-setting precede pharmacology in acute agitation. 6
- When medication is required, options include oral or intramuscular antipsychotics (e.g., olanzapine, haloperidol) and , with attention to pediatric dosing and respiratory monitoring. 5-6
- Restraint and seclusion are last-resort interventions and must be documented per institutional and regulatory standards. 6
Safety-relevant comorbidities
- Weapon access in the home is a modifiable risk factor; counsel caregivers on lethal-means restriction at every visit. 6
- Substance intoxication can mask or precipitate violent behavior; obtain toxicology in acute presentations. 5
- Trauma exposure and current victimization (including sex trafficking and gang violence) require active screening and reporting. 6
Conduct disorder remains contested at the boundary of psychiatry, education, and the juvenile justice system. Several long-standing debates affect day-to-day practice.
Diagnostic boundaries
- The validity of the childhood-onset versus adolescent-onset distinction is supported by longitudinal evidence but blurs in real-world samples with ambiguous histories. 1
- The limited prosocial emotions specifier improves prognostic precision but introduces stigma and reduces treatment optimism among clinicians and families. 1
- Whether DSM-5-TR conduct disorder and ICD-11 conduct-dissocial disorder identify the same construct in research samples is not fully settled. 4
Treatment debates
- The relative effectiveness of MST and FFT across implementations remains contested; effect sizes attenuate in independent replications outside the developer groups. 10
- Off-label antipsychotic use in pediatric aggression has expanded faster than the supporting evidence, raising concerns about cardiometabolic harms in a population that will accumulate decades of exposure. 8
- Whether early identification of callous-unemotional traits leads to harm through labeling outweighs the benefit of targeted early intervention remains an open empirical and ethical question. 1
Systemic and ethical issues
- Racial and socioeconomic disparities in who receives a conduct disorder diagnosis versus a behavior management response in school or referral to the justice system are persistent. 6
- Diversion from juvenile justice into evidence-based treatment is supported by trial evidence but inconsistently implemented. 6,10
- Confidentiality and mandated reporting are routinely in tension when youth disclose ongoing antisocial behavior, victimization, or weapon access. 5
- Conduct disorder requires at least 3 of 15 specified behaviors over the past 12 months, with at least 1 in the past 6 months, plus functional impairment. 3
- The four DSM-5-TR symptom categories are aggression to people and animals, destruction of property, deceitfulness or theft, and serious violations of rules. 3
- Childhood-onset type requires at least one criterion before age 10 and predicts persistence into adult antisocial personality disorder. 3
- The limited prosocial emotions specifier requires at least two of four features (lack of remorse or guilt, callous lack of empathy, unconcern about performance, shallow or deficient affect) over at least 12 months in multiple settings. 3
- Approximately 40% of children with conduct disorder progress to antisocial personality disorder in adulthood. 1,13
- Comorbid ADHD occurs in approximately 30-50% of children with conduct disorder and predicts earlier onset and more severe aggression. 1,7
- Parent management training is first-line for children under approximately age 12. 6,12
- Multisystemic therapy and functional family therapy are first-line for adolescents with serious antisocial behavior, especially those involved with juvenile justice. 6
- Risperidone has the strongest evidence among antipsychotics for reducing severe aggression in youth, particularly with subaverage IQ. 8
- No medication is FDA-approved for conduct disorder; pharmacotherapy targets aggression or comorbidities. 6,8
- Low resting heart rate is one of the most replicated biological correlates of antisocial behavior. 1
- Aggregating high-risk antisocial adolescents in group treatments can produce iatrogenic peer-contagion effects. 1,6
- If the individual is 18 or older and criteria for antisocial personality disorder are met, conduct disorder is not diagnosed. 3
- ICD-11 uses the term conduct-dissocial disorder and includes a similar limited prosocial emotions qualifier. 4
No external funding. No conflicts of interest declared. Peer-review status: pending.
- 1.Fairchild G, Hawes DJ, Frick PJ, Copeland WE, Odgers CL, Franke B, Freitag CM, De Brito SA. Conduct disorder. Nat Rev Dis Primers. 2019;5(1):43. doi:10.1038/s41572-019-0095-y. PMID: 31249310.PMID: 31249310doi:10.1038/s41572-019-0095-y
- 2.TextbookPatterson GR. Coercive Family Process. Eugene, OR: Castalia Publishing; 1982.
- 3.TextbookAmerican Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 5th ed, text rev. Washington, DC: American Psychiatric Association Publishing; 2022.
- 4.TextbookWorld Health Organization. International Classification of Diseases, Eleventh Revision (ICD-11). Geneva: World Health Organization; 2019. Available at https://icd.who.int.Link
- 5.Steiner H; American Academy of Child and Adolescent Psychiatry Work Group on Quality Issues. Practice parameters for the assessment and treatment of children and adolescents with conduct disorder. J Am Acad Child Adolesc Psychiatry. 1997;36(10 Suppl):122S-139S. doi:10.1097/00004583-199710001-00008. PMID: 9334568. (Companion ODD parameter: Steiner H, Remsing L. J Am Acad Child Adolesc Psychiatry. 2007;46(1):126-141. doi:10.1097/01.chi.0000246060.62706.af. PMID: 17195736.)PMID: 9334568doi:10.1097/00004583-199710001-00008
- 6.GuidelineNational Institute for Health and Care Excellence (NICE). Antisocial behaviour and conduct disorders in children and young people: recognition and management. Clinical guideline CG158. London: NICE; 2013 (updated 2017). Available at https://www.nice.org.uk/guidance/cg158.Link
- 7.Faraone SV, Bellgrove MA, Brikell I, Cortese S, Hartman CA, Hollis C, Newcorn JH, Philipsen A, Polanczyk GV, Rubia K, Sibley MH, Buitelaar JK. Attention-deficit/hyperactivity disorder. Nat Rev Dis Primers. 2024;10(1):11. doi:10.1038/s41572-024-00495-0. PMID: 38388701.PMID: 38388701doi:10.1038/s41572-024-00495-0
- 8.Systematic reviewLoy JH, Merry SN, Hetrick SE, Stasiak K. Atypical antipsychotics for disruptive behaviour disorders in children and youths. Cochrane Database Syst Rev. 2017;8(8):CD008559. doi:10.1002/14651858.CD008559.pub3. PMID: 28791693; PMCID: PMC6483473.PMID: 28791693doi:10.1002/14651858.CD008559.pub3
- 9.Webster-Stratton CH, Reid MJ, Marsenich L. Improving therapist fidelity during evidence-based practice implementation: The Incredible Years Program. Psychiatr Serv. 2014;65(6):789-795. doi:10.1176/appi.ps.201200177. PMID: 24686513.PMID: 24686513doi:10.1176/appi.ps.201200177
- 10.RCTLetourneau EJ, Henggeler SW, Borduin CM, Schewe PA, McCart MR, Chapman JE, Saldana L. Multisystemic therapy for juvenile sexual offenders: 1-year results from a randomized effectiveness trial. J Fam Psychol. 2009;23(1):89-102. doi:10.1037/a0014352. PMID: 19203163; PMCID: PMC2710607.PMID: 19203163doi:10.1037/a0014352
- 11.Simmons C, Mitchell-Adams H, Baskin-Sommers A. Environmental Predictors of Within-Person Changes in Callous-Unemotional Traits among Justice-Involved Male Adolescents. J Clin Child Adolesc Psychol. 2022. doi:10.1080/15374416.2022.2093207. PMID: 35900060.PMID: 35900060doi:10.1080/15374416.2022.2093207
- 12.Systematic reviewFurlong M, McGilloway S, Bywater T, Hutchings J, Smith SM, Donnelly M. Behavioural and cognitive-behavioural group-based parenting programmes for early-onset conduct problems in children aged 3 to 12 years. Cochrane Database Syst Rev. 2012;2:CD008225. doi:10.1002/14651858.CD008225.pub2. PMID: 22336837.PMID: 22336837doi:10.1002/14651858.CD008225.pub2
- 13.Odgers CL, Moffitt TE, Broadbent JM, Dickson N, Hancox RJ, Harrington H, Poulton R, Sears MR, Thomson WM, Caspi A. Female and male antisocial trajectories: from childhood origins to adult outcomes. Dev Psychopathol. 2008;20(2):673-716. doi:10.1017/S0954579408000333. PMID: 18423100.PMID: 18423100doi:10.1017/S0954579408000333
More on these topics
Pyromania: Clinical Features, Differential Diagnosis, and Evidence-Based Management
A practical chapter on pyromania — DSM-5-TR criteria, the difference between pyromania and arson, and what the thin evidence base supports for treatment.
Child & Adolescent PsychiatryPyromaniaDifferential DiagnosisOppositional Defiant Disorder
Clinical chapter on Oppositional Defiant Disorder for medical students and psychiatry residents: DSM-5-TR criteria, dimensions, differential, and evidence-based treatment.
Oppositional Defiant DisorderChild & Adolescent PsychiatryDisruptive, Impulse-Control, and Conduct Disorders: A Clinical Overview
A clinical reference on oppositional defiant disorder, conduct disorder, intermittent explosive disorder, kleptomania, and pyromania across the lifespan.
Conduct DisorderChild & Adolescent PsychiatryIntermittent Explosive DisorderDisruptive Mood Dysregulation Disorder (DMDD): Diagnosis, Differential, and Management
A clinical reference on DMDD — the DSM-5-TR childhood diagnosis built to curb pediatric bipolar overdiagnosis, with assessment and treatment guidance.
Differential DiagnosisChild & Adolescent PsychiatryDisruptive Mood Dysregulation DisorderSelective Mutism: Diagnosis, Differential, and Evidence-Based Treatment
A clinical reference on selective mutism — DSM-5-TR criteria, anxiety-spectrum framing, assessment, and graded behavioral and pharmacologic treatment.
Anxiety DisordersPsychopharmacologyChild & Adolescent PsychiatrySeparation Anxiety Disorder
Excessive, developmentally inappropriate fear of separation from attachment figures — DSM-5-TR diagnosis, evaluation, and evidence-based treatment.
Anxiety DisordersChild & Adolescent PsychiatrySeparation Anxiety Disorder